Azitra, Inc.
AZTR · XNYSCIK 1701478fmd_01FZG6DVHBP80AH80AFV3D6VAHManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2022 to Sep 30, 2026, 19 periods
| Line item | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Total revenues | 0 | 1 | 0 | 0 |
| Research and development | 6 | 4 | 5 | 5 |
| Total operating expenses | 10 | 8 | 11 | 11 |
| Operating income | (9) | (7) | (11) | (11) |
| Interest expense | 0 | 0 | 0 | 0 |
| Other non-operating income (expense) | (1) | (4) | 2 | 0 |
| Income before taxes | (11) | (11) | (9) | (11) |
| Income tax expense | – | 0 | 0 | 0 |
| Net income from continuing operations | – | (11) | (9) | (11) |
| Net income | (11) | (11) | (9) | (11) |
| Net income to common shareholders | (13) | (13) | (9) | – |